newsfilter
← Latest News
PR Newswire·

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...